date,title,source
Oct-26-18,"Checkpoint Therapeutics, Inc. (CKPT) Q3 Earnings Preview: What to Watch Ahead of the Release",Zacks
Dec-25-18,"Are Checkpoint Therapeutics, Inc.s (NASDAQ:CKPT) Interest Costs Too High?",Simply Wall St.
Jan-07-19,Checkpoint Therapeutics Initiates Registrational Development Programs for Anti-PD-L1 Antibody CK-301,GlobeNewswire
Mar-13-19,Checkpoint Therapeutics Announces Issuance of Two New Patents for EGFR Inhibitor CK-101,GlobeNewswire
Mar-15-19,Checkpoint Therapeutics Reports Full-Year 2018 Financial Results and Recent Corporate Highlights,GlobeNewswire
Apr-03-19,Checkpoint Therapeutics to Present at the 2019 H.C. Wainwright Global Life Sciences Conference,GlobeNewswire
Apr-29-19,CKPT: Disruptive Pricing Model to Fire Up $20B+ Market,Zacks Small Cap Research
